Boston Scientific (BSX) vs CONMED (CNMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CONMED (CNMD) has outperformed Boston Scientific (BSX) over the past year, losing 3.6% versus a loss of 56.6%. Over five years, BSX leads with a -4.2% price change compared with -68.9% for CNMD. Boston Scientific is the larger company by market cap ($60.33 billion vs $1.35 billion), about 44.8 times the size.
On valuation, CONMED trades at a lower forward P/E (9.4x vs 12.3x for Boston Scientific). CONMED pays a dividend yielding 0.45%, while Boston Scientific does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BSX | CNMD |
|---|---|---|
| Share price | $41.63 | $44.94 |
| Market cap | $60.33B | $1.35B |
| 1-day change | +0.12% | +1.61% |
| YTD return | -56.39% | +8.94% |
| 1-year return | -56.64% | -3.64% |
| 5-year return | -4.19% | -68.86% |
| P/E ratio (TTM) | 16.85 | 24.29 |
| Forward P/E | 12.31 | 9.40 |
| EPS (TTM) | $2.47 | $1.85 |
| Dividend yield | 0.00% | 0.45% |
| Annual dividend | $0.00 | $0.20 |
| Revenue (latest FY) | $20.07B | — |
| Revenue growth (YoY) | +19.87% | — |
| Net income (latest FY) | $2.89B | — |
| Gross margin | 69.01% | — |
| Operating margin | 18.00% | — |
| Net margin | 14.41% | — |
| 52-week high | $105.65 | $53.66 |
| 52-week low | $41.44 | $31.44 |
| Distance from 52-week high | -60.60% | -16.25% |
| Analyst consensus | buy | none |
| Avg. price target upside | +43.89% | +1.25% |
| Average volume | 19.71M | 493.66K |
| Shares outstanding | 1.45B | 29.95M |
| Employees | 59,000 | 3,900 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Boston Scientific is about 44.8 times larger than CONMED by market value ($60.33B vs $1.35B).
- CNMD has outperformed BSX by 53.0 percentage points over the past year.
- CONMED trades at a higher earnings multiple (24.3x vs 16.9x trailing P/E).
About Boston Scientific
BSX stock →Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.
Health Care · Medical/Dental Instruments · 59,000 employees
About CONMED
CNMD stock →CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 3,900 employees
BSX vs CNMD FAQ
Which is bigger, Boston Scientific or CONMED?
Boston Scientific (BSX) is larger, with a market capitalization of $60.33B compared with $1.35B for CONMED (CNMD).
Which stock has performed better over the past year, BSX or CNMD?
CNMD returned -3.64% over the past 12 months, compared with -56.64% for BSX (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, BSX or CNMD?
BSX has the lower trailing P/E at 16.9, versus 24.3 for CNMD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Boston Scientific or CONMED?
CONMED pays a dividend yielding 0.45%, while Boston Scientific does not currently pay a regular dividend.
Are Boston Scientific and CONMED in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Boston Scientific and Biotechnology: Electromedical & Electrotherapeutic Apparatus for CONMED.